Hyperiplant Rx
Hyperiplant Rx is a complementary medicine product from Schwabe Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it under the SL conditions. The public price ranges from CHF 32.70 to CHF 58.90 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Schwabe Pharma AG
- ATC code
- N06AX25
- IT group
- 51.06 Antidepressiva
- Active substances
- Hyperici herbae extractum methanolicum siccum
- Preparation type
- Complementary medicine
- On the SL since
- 01/11/2010
- Last price change
- 01/11/2010
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 600 mg | 40 Stk | CHF 14.99 | CHF 32.70 | 01/11/2010 | B | 7680585440014 |
| Filmtabl 600 mg | 100 Stk | CHF 39.05 | CHF 58.90 | 01/11/2010 | B | 7680585440021 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Hyperiplant Rx covered by Swiss health insurance?
Yes. Hyperiplant Rx is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Hyperiplant Rx cost in Switzerland?
The public price is the maximum price set by the FOPH and for Hyperiplant Rx ranges from CHF 32.70 to CHF 58.90 per pack. The ex-factory price ranges from CHF 14.99 to CHF 39.05. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages